Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer

  • Claudia Geismann
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Mascha Morscheck
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Dorothee Koch
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Frank Bergmann
    4Institute of Pathology, University of Heidelberg;
  • Hendrik Ungefroren
    2Clinic of General Surgery and Thoracic Surgery, and
  • Alexander Arlt
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Ming-Sound Tsao
    6Division of Applied Molecular Oncology, Ontario Cancer Institute, Toronto, Ontario, Canada; and
  • Max G. Bachem
    7Department of Clinical Chemistry and Pathobiochemistry, University of Ulm, Ulm, Germany
  • Peter Altevogt
    5Tumor Immunology Programme, German Cancer Research Center, Heidelberg, Germany;
  • Bence Sipos
    3Department of Pathology, UKSH-Campus Kiel, Kiel, Germany;
  • Ulrich R. Fölsch
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Heiner Schäfer
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,
  • Susanne Sebens Müerköster
    1Clinic of Internal Medicine, Laboratory of Molecular Gastroenterology and Hepatology,

抄録

<jats:title>Abstract</jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is thought to originate from ductal structures, exhibiting strong desmoplastic reaction with stromal pancreatic myofibroblasts (PMF), which are supposed to drive PDAC tumorigenesis. Previously, we observed high expression of the adhesion molecule L1CAM (CD171) in PDAC cells accounting for chemoresistance. Thus, this study aimed to investigate whether PMFs are involved in the induction of tumoral L1CAM and whether this contributes to malignant transformation of pancreatic ductal cells and PDAC tumorigenesis. Immunohistochemistry of tissues from chronic pancreatitis specimens revealed considerable L1CAM expression in ductal structures surrounded by dense fibrotic tissue, whereas no L1CAM staining was seen in normal pancreatic tissues. Using the human pancreatic duct cell line H6c7, we show that coculture with PMFs led to a transforming growth factor-β1 (TGF-β1)–dependent up-regulation of L1CAM expression. Similarly, L1CAM expression increased in monocultured H6c7 cells after administration of exogenous TGF-β1. Both TGF-β1– and PMF-induced L1CAM expression were independent of Smad proteins but required c-Jun NH2-terminal kinase activation leading to the induction of the transcription factor Slug. Moreover, Slug interacted with the L1CAM promoter, and its knockdown abrogated the TGF-β1– and PMF-induced L1CAM expression. As a result of L1CAM expression, H6c7 cells acquired a chemoresistant and migratory phenotype. This mechanism of TGF-β1–induced L1CAM expression and the resulting phenotype could be verified in the TGF-β1–responsive PDAC cell lines Colo357 and Panc1. Our data provide new insights into the mechanisms of tumoral L1CAM induction and how PMFs contribute to malignant transformation of pancreatic duct cells early in PDAC tumorigenesis. [Cancer Res 2009;69(10):4517–26]</jats:p>

収録刊行物

  • Cancer Research

    Cancer Research 69 (10), 4517-4526, 2009-05-15

    American Association for Cancer Research (AACR)

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ